Establishing outcome measures in early knee osteoarthritis by Emery, Carolyn et al.
        
Citation for published version:
Emery, C, Whittaker, JL, Mahmoudian, A, Lohmander, LS, Roos, EM, Bennell, KL, Toomey, CM, Reimer, RA,
Thompson, D, Ronsky, JL, Kuntze, G, Lloyd, DG, Andriacchi, T, Englund, M, Kraus, VB, Losina, E, Bierma-
Zeinstra, S, Runhaar, J, Peat, G, Luyten, FP, Snyder-Mackler, L, Risberg, MA, Mobasheri, A, Guermazi, A,
Hunter, DJ & Arden, NK 2019, 'Establishing outcome measures in early knee osteoarthritis', Nat Rev Rheumatol,
vol. 15, no. 7, pp. 438-448. https://doi.org/10.1038/s41584-019-0237-3
DOI:
10.1038/s41584-019-0237-3
Publication date:
2019
Document Version
Peer reviewed version
Link to publication
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 07. Dec. 2019
1 
 
Establishing outcome measures in early knee osteoarthritis  1 
Carolyn A Emery1*, Jackie L Whittaker2, Armaghan Mahmoudian3, L Stefan Lohmander4, Ewa M Roos5, Kim 2 
L Bennell6, Clodagh M Toomey7, Raylene A Reimer8, Dylan Thompson9, Janet L Ronsky10, Gregor Kuntze11, 3 
David G Lloyd12, Thomas Andriacchi13, Martin Englund14, Virginia B Kraus15, Elena Losina16, Sita Bierma-4 
Zeinstra17-19, Jos Runhaar18,19, George Peat20,21, Frank P Luyten22, Lynn Snyder-Mackler23, May Arna 5 
Risberg24, Ali Mobasheri18,23-26, Ali Guermazi27, David J Hunter28, Nigel K Arden25,29 6 
1 Sport Injury Prevention Research Centre, Faculty of Kinesiology and Alberta Children’s Hospital Research 7 
Institute and McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of 8 
Calgary, Calgary, Canada  9 
2Department of Physical Therapy, Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, 10 
Canada  11 
3Division of Rheumatology, Skeletal Biology & Engineering Research Center, University Hospitals KU 12 
Leuven, Belgium  13 
4Department of Clinical Sciences Lund, Orthopaedics, Lund University, Lund, Sweden  14 
5Department of Sports and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark  15 
6Centre for Health, Exercise and Sports Medicine, University of Melbourne, Melbourne, Australia  16 
7 Sport Injury Prevention Research Centre, Faculty of Kinesiology University of Calgary, Calgary, Canada  17 
8Faculty of Kinesiology and Department of Biochemistry and Molecular Biology, University of Calgary, 18 
Calgary, Canada  19 
9Department for Health, University of Bath, Bath, UK 20 
10Schulich School of Engineering, Faculty of Kinesiology, and McCaig Institute for Bone and Joint Health, 21 
Cumming School of Medicine, University of Calgary, Calgary, Canada  22 
2 
 
11 Sport Injury Prevention Research Centre, Faculty of Kinesiology and Alberta Children’s Hospital 23 
Research Institute and McCaig Institute for Bone and Joint Health, Cumming School of Medicine, 24 
University of Calgary, Calgary, Canada  25 
12Gold Coast Centre for Orthopaedic Research, Engineering and Education (GCORE), Menzies Health 26 
Institute Queensland, Griffith University, Australia  27 
13Department of Mechanical Engineering and Department of Orthopedic Surgery, Stanford University, 28 
Stanford CA, Palo Alto Veterans Affairs Health Care System, Palo Alto, CA, USA 29 
14Clinical Epidemiology Unit, Orthopedics, Department of Clinical Sciences Lund, Lund University, Lund, 30 
Sweden  31 
15Duke Molecular Physiology Institute and Division of Rheumatology, Department of Medicine, Duke 32 
University School of Medicine, Durham, NC, USA 33 
16The Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Harvard 34 
Medical School and Boston University School of Public Health, Boston, MA USA  35 
17Department of Orthopaedics, Erasmus MC - University Medical Center Rotterdam, The Netherlands;  36 
18D-BOARD Consortium, European Commission Framework 7 programme 37 
19Department of General Practice, Erasmus MC - University Medical Center Rotterdam, The Netherlands  38 
20 Research Institute for Primary Care & Health Sciences, Keele University, Staffordshire, UK  39 
21 Primary Care Versus Arthritis, UK 40 
22Division of Rheumatology, Skeletal Biology & Engineering Research Center, University Hospitals KU 41 
Leuven, Belgium  42 
23Departments of Physical Therapy and Biomedical Engineering, STAR Health, University of Delaware, 43 
Newark, Delaware, USA  44 
3 
 
24Norwegian Research Center for Active Rehabilitation, Department of Sports medicine, Norwegian School 45 
Sport Sciences and Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway  46 
53Department of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, 47 
Lithuania;  48 
24 Queen’s Medical Centre, Nottingham, UK 49 
25Centre for Sport, Exercise and Osteoarthritis Versus Arthritis, UK  50 
26APPROACH Consortium, European Commission Innovative Medicines Initiative  51 
27Boston University School of Medicine, Boston, USA  52 
28Institute of Bone and Joint Research, Kolling Institute, University of Sydney and Rheumatology 53 
Department, Royal North Shore Hospital, Sydney, Australia  54 
29Oxford University, Oxford, UK  55 
 56 
Email: caemery@ucalgary.ca 57 
 58 
 59 
  60 
  61 
4 
 
Abstract 62 
The classification and monitoring of individuals with early knee osteoarthritis (OA) is an important strategy 63 
for the design and evaluation of therapeutic interventions. Such an approach requires the identification of 64 
appropriate outcomes measures. Potential outcome measures for early OA include patient-reported 65 
outcomes (such as measures of pain, function or quality of life), features of clinical examination (such as 66 
joint line tenderness and crepitus (that is, grating and crackling sounds), objective measures of physical 67 
function, levels of physical activity, movement biomechanics, structural assessments such as magnetic 68 
resonance imaging (MRI) and biochemical markers in body fluid. Patient characteristics such as adiposity 69 
and biomechanics of the knee could also have  relevance to early OA. Importantly, future research is 70 
needed to enable the selection of outcome measures that are feasible, reliable, and validated in those at 71 
risk of OA and an early knee OA population. In this Perspectives paper, potential outcome measures of 72 
individuals with early symptomatic knee osteoarthritis (OA) are discussed, including those that could be 73 
of use in clinical practice as well as research settings. 74 
 75 
[H1] Introduction 76 
Osteoarthritis (OA) is a leading cause of chronic pain, disability, and health care utilization, with knee OA 77 
contributing the greatest burden1-4. OA is associated with increased rates of comorbidity (for example, 78 
obesity and heart disease)1 and ranks the 13th 2 most burdensome amongst all forms of disability world-79 
wide. The incidence, burden and socioeconomic impact of OA is considerable and growing3, 5. Therefore, 80 
a shift in the treatment approach is needed from treating patients once they have established OA to a 81 
proactive approach that focuses on mitigating risk factors. The classification and monitoring of early OA, 82 
on a trajectory from normal to symptomatic and/or radiographic OA, would provide an opportunity in 83 
clinical practice and research for the development and evaluation of interventions to prevent or slow down 84 
the disease process at a time it is probably more amenable to modification.  85 
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Although the definition of early OA and appropriate outcomes are under development, OA is probably 86 
heterogeneous in terms of its presentation and progression. Knee OA might progress slowly over a period 87 
of ten or more years, rapidly, or not at all6. Predicting the development and progression of disease through 88 
identifying risk factors and mechanisms of OA is important in chronic disease management to inform 89 
targeted OA prevention and treatment strategies. This strategy is difficult because of the heterogeneous 90 
presentation of OA; however, the availability of increasingly sophisticated statistical and computational 91 
methods, microsimulation modelling, and large population-based cohort studies make this approach 92 
increasingly viable. For example, widely-used online prediction tools are now available for evaluating 93 
future risk of osteoporotic fractures and for guiding clinicians in preventive management of osteoporosis7-94 
9. Comparable reliable and validated outcomes for early knee OA will inform the evaluation of risk factors 95 
for the progression of early OA. More than one set of risk factors and models will probably be needed to 96 
predict early OA in the future. The Rotterdam and Chingford studies (two prospective population-based 97 
studies) have demonstrated an ability to predict incident radiographic knee OA using a combination of 98 
clinical, genetic, and radiographic factors10. When performing risk assessment and creating a predictive 99 
model for early knee OA, many aspects need to be considered: the definitions of the outcome and 100 
prognostic factors; the duration of the clinically relevant prediction period; and the setting in which the 101 
risk prediction tool will be used (for example, primary care, secondary care or a research setting). For 102 
instance, expensive and intensive predictive tools such as MRI scans and biochemical markers might be 103 
restricted to secondary care and/or a research setting. 104 
In this Perspectives article, we highlight considerations for best practice in the selection of outcome 105 
measures for use in clinical and research settings to evaluate patients at initial presentation of early knee 106 
OA across different outcome domains: patient-reported outcomes, clinical examination, physical function, 107 
adiposity, physical activity, nutrition, biomechanical outcomes, imaging features and biochemical 108 
markers11. We suggest outcome measures that could be considered for use in individuals with early knee 109 
OA in clinical care and research settings using published evidence (primarily from post-traumatic and 110 
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established OA populations), emerging evidence (ongoing studies), and clinical expertise (Box 1). The 111 
outcome measures highlighted are relevant to individuals that are at risk of OA and fit the provisional 112 
criteria for early knee OA based on patient reported outcomes of pain and function, together with clinical 113 
signs (joint line tenderness or crepitus) and a radiographic Kellgren-Lawrence (KL) grade of 0-1 12. Although 114 
proposed as important evidence-informed clinical outcome measures, these outcome measures will 115 
require additional validation and possible modification to suit local primary care and other healthcare 116 
settings, as well as periodical updates. 117 
 118 
[H1] Patient-reported outcomes 119 
Patient-reported outcomes are any report of a patient’s health status that comes directly from the patient 120 
without interpretation by others (for example, the clinician). These measures commonly take the form of 121 
a questionnaire. Most relevant patient-reported outcome measures have been developed to either assess 122 
individuals with a knee injury (for example, International Knee Documentation Committee 2000 123 
(IKDC2000)) or established OA (for example, Western Ontario and McMaster Osteoarthritis Index 124 
(WOMAC)); although, one questionnaire has been developed to cover the full spectrum from injury to 125 
established OA (the Knee Injury and Osteoarthritis Outcome Score (KOOS)). The relative merits of these 126 
and other available instruments that measure self-reported pain, function, and quality of life have been 127 
the subject of previous reviews13, 14. Today measures, such as PROMIS, are often developed using 128 
computer adaptive strategies which may also prove to be relevant for use in people with early knee OA15. 129 
Many of the considerations that influence the choice of measure in established OA (for example, 130 
respondent burden, cost or availability) apply also in early OA.  131 
Ultra-brief (one or two domains) unidimensional generic measures, such as the 11-point Numerical Rating 132 
Scale (NRS-11), the 36-Item short form health survey (SF-36)  bodily pain scale (SF-BP 36), have been 133 
recommended in previous reviews for established OA16 and are probably applicable also in early OA. 134 
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However, the disadvantage of unidimensional measures is a restricted view of the pain character and 135 
intensity16, 17, which is probably inappropriate based on emerging evidence from qualitative studies in 136 
patients with early knee OA18-20. For instance, these patients report that their initial symptoms can be 137 
experienced as ‘an awareness’ of the knee, loss of confidence, or needing to ‘be careful’ as opposed to 138 
‘pain’. The KOOS knee-related quality of life subscale includes consideration of questions on these 139 
aspects14,15. Further, reporting OA pain as ‘constant’ or ‘present on most days’ might give floor effects (i.e., 140 
most individuals may report at the lower end of the scale) in early OA as these patients often report 141 
episodic and intermittent pain with certain activities. For example, pain during ascending or descending 142 
stairs seemed to be the earliest functional difficulty reported in the OA initiative21. Accordingly, the 143 
intermittent and constant assessment of pain score (ICOAP) questionnaire, which includes a subscale on 144 
intermittent symptoms, has an increasing amount of evidence supporting its’ reliability and validity22. 145 
Another important consideration is that the early phase of knee OA is often associated with the emergence 146 
of adaptive behaviour. Symptom frequency and intensity might be minimized through the selection of 147 
behaviours (for example, performing some activities less often), optimization of behaviours (for example, 148 
advanced planning of activities, including anticipatory analgesic use), and compensatory adaptations (for 149 
example, modifying the way activities are performed)23. Therefore, consideration of adaptive behaviour is 150 
a legitimate topic for outcome measurement in early OA24, an example of which is the Questionnaire to 151 
Identify Knee Symptoms (QuIKS). QuIKS includes questions such as “I am considering stopping a favorite 152 
activity due to my knees” and “I am considering changing my exercise routine due to my knee problems”25.  153 
The KOOS was developed for self-reporting of patient-relevant outcomes across the lifespan, from time of 154 
knee injury and potential knee OA onset to severe OA26-29. In five separate subscales this tool assesses 155 
perceived pain and other symptoms (e.g., stiffness, grinding, catching), perceived difficulty with function 156 
during daily life and sport and recreational activities, and knee-related quality of life. The KOOS 157 
measurement properties have been reported in studies of young, middle-aged, and elderly groups with 158 
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knee injury or OA, and across the spectrum of14. A comprehensive literature search identified 37 eligible 159 
papers evaluating KOOS measurement properties in participants with knee injuries and/or osteoarthritis 160 
(OA) and found that KOOS demonstrates adequate content validity, internal consistency, test-retest 161 
reliability, construct validity and responsiveness for age- and condition-relevant subscales14.The KOOS is 162 
feasible to administer electronically and in paper form and KOOS scoring instructions and population-163 
based KOOS reference data are available. In addition, longitudinal KOOS data have been collected from 164 
more than 100,000 patients in surgical registries of anterior cruciate ligament reconstruction and knee 165 
replacement facilitating comparisons to many different populations30, 31. In addition, for the interested 166 
researcher, KOOS data are freely available and collected from the cohort of patients who are at increased 167 
risk of OA and the cohort of patients with established disease from the NIH-sponsored OA Initiative32. The 168 
OA initiative also collects a wide range of other self-reported, clinical and imaging data32. The cohort at 169 
risk include people with symptoms and two or more risk factors (including knee injury) but without 170 
radiographic OA32. 171 
The ICOAP was designed to evaluate the pain experience in people with OA. It includes pain intensity, 172 
frequency, and impact on mood, sleep and quality of life. It is intended to be used alongside a measure of 173 
physical function22. OA-specific measures developed for more advanced OA cannot be assumed to have 174 
adequate psychometric properties when applied to early OA. Yet, the requirement for adequate 175 
performance in early OA must be balanced against the benefits for a coherent evidence base that comes 176 
from using common measures across the spectrum from early to advanced OA. Of existing measures, the 177 
KOOS and ICOAP seem to best strike this balance and are therefore strong candidates for evaluating early 178 
knee OA (Box 1), particularly as these instruments focus on different aspects; both have the advantage of 179 
being freely available. Published reviews of the psychometric properties of these two measures require 180 
systematic updating with specific attention to their performance in early OA.  181 
 [H1] Clinical examination outcomes 182 
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Clinical examination outcomes are relevant in research and are easy to  perform in primary care. Joint line 183 
tenderness (tibiofemoral and/or patellofemoral joint lines) at baseline was suggested to be a strong 184 
predictor of five-year pain progression (moderate progression adjusted OR=3.9 (95% CI; 2.3 - 6.6)33 in the 185 
CHECK cohort (n=705) that included patients with newly onset knee pain or stiffness34. Several studies 186 
have evaluated the ability of physical signs to predict the clinical onset of structural radiographic OA in 187 
patients with an increased risk of OA33-37. Data from the HONEUR Study, which included 549 participants 188 
who were recruited at the first presentation of knee pain in primary care, suggested that joint line 189 
tenderness, crepitus (that is, grating, crackling, popping sounds), pain with passive flexion, and a self-190 
reported swollen knee predicted incident radiographic tibiofemoral knee OA after 6 years35. Using MRI 191 
features of knee OA as an outcome measure, data from the  general population Rotterdam Study showed 192 
that joint line tenderness together with the ‘feeling of giving way’ were associated with the incidence of 193 
tibiofemoral knee OA, whereas crepitus was identified as a good predictor of patellofemoral OA36, 37.  194 
Easily assessable measures from physical examination might be associated with future OA development, 195 
including joint line tenderness and crepitus, even in the absence of radiologic findings of OA (Box 1). 196 
Clinical examination of these features had good inter-observer reliability in a population with evident knee 197 
osteoarthritis if a standardised approach to such assessment is used38. However, these clinical assessment 198 
components require further examination of reliability and validation for research settings in early knee OA 199 
and standardization for use in clinical settings. 200 
[H1] Physical function outcomes 201 
Given that the early pre-radiographic stage of OA is associated with intermittent symptoms and adaptive 202 
physical behaviour, the clinical evaluation of patients with, or at risk of, early knee OA should incorporate 203 
robust outcome measures of physical function39. Currently, no consensus exists regarding which outcomes 204 
are most relevant for use in this population. For the purposes of this Perspective article, physical function 205 
is operationally defined as ‘physiological functions’ or ‘the ability to move around and to perform daily 206 
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activities’ that can be classified as ‘body functions and structure’ or ‘activities and participation’, 207 
respectively, using the World Health Organization International Classification of Functioning, Disability and 208 
Health (ICF) model40. As physical function is multi-dimensional, both performance-based and physical 209 
impairment measures (which might require specialized pieces of equipment and raters) are discussed in 210 
this section. Emerging evidence suggest that some of these outcome measures might be suitable for the 211 
evaluation of early OA and those at risk of OA (Table 1)41-46.  212 
A range of performance-based measures are available although the degree to which their measurement 213 
properties are established and the range of populations they have been used in varies (Table 1). Measures 214 
that have undergone fairly extensive investigation include the Single Leg Hop for distance test43, 44, 47-50, the 215 
Cross Hop for distance43, 47-51, the 6-meter Timed Hop Test43, 47-50, the Star Excursion  and similar Y-balance 216 
Btest44, 51-56, the 30-second Chair Sit-to-Stand Test57-59, and the 6-minute walk test41, 42, while there is 217 
emerging evidence for the Vertical Drop Jump 44, 60, the Single Leg Squat 44, 61-63, Unipedal Dynamic Balance 218 
test 44, 64 and 20-meter Shuttle Run44, 65. The most commonly reported outcome of physical impairment is 219 
quadriceps muscle strength44, 47, 48, 52, 66, however, there may also be value in considering the strength of 220 
other lower extremity muscles including the hamstring, hip abductor and hip adductor muscles67; 221 
although, insufficient information is available to advocate for specific contraction mode (i.e., isotonic, 222 
isokinetic or isometric) or type (i.e., concentric or eccentric).  223 
Because of floor and ceiling effects (i.e., most individuals report a minimum – floor, or maximum – ceiling 224 
score), separate measures are required to cover the wide range of ages and abilities of patients with early 225 
knee OA in both clinical and research settings . Functional outcomes that should be considered for use in 226 
research and in clinical physical and exercise therapy practice based on their measurement properties and 227 
ability to span the full spectrum of patient age and abilities include the Single Leg Hop for distance, 30-228 
second Chair Sit-to-Stand Test, 6-minute walk test, Star Excursion Balance Test and a quadriceps strength 229 
measure. The performance-based outcomes should be administered in a standardized, validated and 230 
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reproducible fashion to enable detection of change over time; video demonstrations and explicit 231 
instructions for standardized testing are available online (see related links). Further research validating 232 
functional outcomes in ‘at risk’ (e.g., intra-articular knee injury, obesity, varus/valgus alignment 233 
abnormality) and ‘early-OA’ populations is required and this research should inform the periodic updating 234 
of these suggested functional outcomes. 235 
 236 
[H1] Modifiable lifestyle-related outcomes 237 
The presence of modifiable risk factors related to lifestyle, such as obesity, dietary inadequacies, and 238 
physical inactivity might lead to accelerated disease onset and progression through a combination of 239 
mechanical and systemic mechanisms68. Identifying these modifiable risk factors in early knee OA is 240 
important for the prevention of OA.  241 
Several measures of adiposity or weight have been studied in established OA, but less so in early OA. These 242 
include BMI, waist-height ratio (WHR) and waist circumference69-73. The location of fat deposits influences 243 
their metabolic and inflammatory potential and therefore may be important considerations74 . A high 244 
waist-height ratio or waist circumference (indicative of abdominal adiposity) was associated with an 245 
increased risk of OA progression73; however, neither outcome was associated with the loss of tibial or 246 
patellar cartilage volume or defects in adults in the community with pre-radiographic OA 75, 76. To better 247 
understand this relationship, a distinction between subcutaneous and visceral adiposity using valid 248 
assessment techniques (e.g. MRI or CT assessment) is likely needed. Measurements of fat mass (kg), 249 
percentage fat mass (percentage of total mass) and fat mass index (FMI; fat mass/height2), can be obtained 250 
using dual-energy x-ray absorptiometry or bioelectrical impedance analysis, hence permitting a direct 251 
measure of total adiposity77. Total fat mass is positively associated with an increased risk of knee cartilage 252 
defects and the presence of bone marrow lesions in healthy individuals (aged 25-60 years)78 and medial 253 
tibiofemoral cartilage volume loss over 2-10 years in adults aged 51-81 years79, 80. A systematic review 254 
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reported moderate evidence for the relationship between obesity (that is, increasing weight, BMI or total 255 
body fat mass) and the presence of bone marrow lesions in the knee in individuals with OA72. In addition 256 
to contributing to an increased mechanical load, adiposity is thought to have a metabolic and pro-257 
inflammatory function in OA; therefore, a direct measure of adiposity such as fat mass, percentage fat 258 
mass or FMI might be useful in the assessment of early-stage OA81-84. 259 
Physical activity is a modifiable outcome that might delay the onset of functional limitation, prevent 260 
obesity, and is essential for normal joint health85. In addition, physical activity can reduce pain and 261 
disability among individuals with OA and increase their physical performance and self-efficacy86-88. Light or 262 
moderate intensity physical activity might protect against the onset of disability related to symptomatic 263 
OA, whereas a sedentary lifestyle or high levels of strenuous physical activity are considered risk factors89-264 
91. Many variations of self-reported measures of physical activity exist including global or short recall 265 
questionnaires, although most have limited accuracy89-91. Wearable monitors that measure body motion 266 
can be used to assess physical activity and energy expenditure. The most commonly used sensor, validated 267 
across multiple populations, is an accelerometer (for example, Actigraph)92, which captures frequency, 268 
intensity, and duration of physical activity in a time-stamped manner. The large selection of off-the-shelf 269 
accelerometers, often contained in mobile phones, might be more suitable in a primary care setting to 270 
measure physical activity as they are less expensive, easier to use, and widely available93, 94. Most 271 
accelerometers, however, are not validated to measure cycling or swimming. In general, objective 272 
measures of physical activity such as accelerometer outcomes compared with self-reporting have stronger 273 
relationships with function in OA95 and are a more accurate assessment of physical activity and sedentary 274 
lifestyle.  275 
Nutrition interventions such as weight loss96, 97 are lifestyle-related changes that can potentially improve 276 
OA symptoms. Beyond the link between obesity and knee OA (and therefore the important contribution 277 
of weight loss)98, 99, the contribution of nutritional factors is an emerging and important area of research, 278 
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although limited clinical evidence is available to date. For example, low dietary intakes of fibre100 or omega-279 
3 polyunsaturated fatty acids101, and high fat diets102 are risk factors for OA and/or worsening of pain in 280 
OA and might therefore warrant monitoring in early OA. Many of the nutrients or dietary patterns tested 281 
to date probably contribute to pathology via alterations in body weight or inflammation, although the 282 
direct effects of these factors requires further investigation. The tools to monitor dietary intake are 283 
numerous (for example, the Food Frequency Questionnaire (FFQ), 24-hour dietary recall (either the paper-284 
based or web-based automated self-administered 24-hour dietary recall (ASA24) assessment tools103) and 285 
the 3-day or 7-day weighed food record) and need to be assessed for each clinical or research setting. In 286 
addition, tools to assess adherence to diets that reduce inflammation such as the Mediterranean Diet 287 
Adherence Screener104 might also warrant use in future.  288 
Hence, objective measures of adiposity are desirable. BMI is a useful outcome measure for assessing 289 
adiposity in a primary clinical setting because of its familiarity, validity, and reference ranges. However, 290 
BMI has limitations for use in young athletes. Although weight loss can improve OA symptoms, further 291 
research is needed to identify a means of assessing important OA-related nutritional factors. Assessment 292 
of physical activity using a validated accelerometer, to accurately capture activity through each domain 293 
and intensity, is a promising area that requires future study.  294 
 295 
[H1] Biomechanical outcomes 296 
Biomechanical outcomes are measures of joint mechanics typically collected in a research setting, but 297 
sometimes taken in a primary care setting. Joint mechanics can be employed to assess OA severity, but 298 
also for understanding the causes of OA onset and progression. For example, altered joint mechanics 299 
following knee injury might contribute to the onset and development of post-traumatic OA39. Indirect 300 
evidence to support this concept comes from observations of altered joint movement, loading, and muscle 301 
activation patterns following injury105-110, with radiographic knee OA (KL≥2)111-113, with aging114, 115 and pre 302 
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and post joint arthroplasty116-118. Abnormal joint alignment119, 120, alteration of the external knee adduction 303 
moment (KAM) and increased varus alignment are often regarded as indicators of altered joint mechanics 304 
associated with increased OA severity113. However, joint mechanics in OA might also change because of 305 
other factors including loss of dynamic joint stability121, 122, muscle atrophy123, neuromuscular inhibition124, 306 
muscle weakness,125-127 and compensatory muscle activation mechanisms111, 112, 117. These changes might 307 
alter cartilage loading and contact mechanics. Indeed, some studies indicate that changes in tibiofemoral 308 
cartilage contact locations39, 128, elongated path lengths129, force magnitudes106, 130, 131, and deformations128, 309 
129 are associated with OA onset and progression. In turn, OA progression might be caused by progressive 310 
degradation of cartilage through interactions of articular movement and cartilage loading abnormalities, 311 
chronic inflammation, resultant tissue remodelling, and other OA risk factors by increasing the 312 
susceptibility of cartilage and subchondral bone to damage and degradation at regions inadequately 313 
adapted to these altered loads128, 132-136. Over time, this process might result in altered cartilage thicknesses 314 
and clinically relevant cartilage thinning in different regions of the articular cartilage surfaces . To verify 315 
this mechanism, longitudinal data are needed of the joint mechanics, cartilage thickness, and cartilage 316 
structure and integrity in OA137, 138. Integration of this information with other risk factors for OA-related 317 
changes might inform the development of novel patient-specific, diagnostic or predictive models to aid in 318 
early patient screening, intervention efficacy monitoring, and the development of new therapeutics130, 131, 319 
133, 139, 140. Armed with these data and models, new wearable monitors might enable biomechanical 320 
outcomes assessment in the clinic and community134-136, 141, 142, and might provide the possibility of 321 
developing and monitoring personalized treatment plans.  322 
Presently, the joint range of motion is a suggested measure that could be collected in a primary care setting 323 
to assess OA severity.  The other biomechanical outcomes mentioned above (e.g., KAM, kinematics, 324 
electromyography, cartilage loading) although used to understand the mechanisms of OA progression and 325 
currently not feasibly collected in most clinical settings, are an important component for consideration in 326 
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research settings to inform orthotics design, exercise interventions, bracing, and surgical interventions. In 327 
the future, validated wearable monitors might help assess biomechanical outcomes of early interventions 328 
in the clinic and community. Evidence suggest that outcome measures are not independent but rather 329 
variation in one outcome measure (for example, biomechanical outcomes) can influence the quantitative 330 
state of another measure (for example, biochemical markers or imaging outcomes)143-147. Thus, future 331 
research should consider the interaction between different outcome measures to potentially increase the 332 
sensitivity of detecting early OA132, 144. 333 
[H1] Imaging outcomes 334 
OA is a complex syndrome that at the local level, is best characterised as a whole joint disease involving 335 
multiple tissue pathologies. In attempting to characterise and monitor the variety of OA structural 336 
components a number of different imaging modalities have been used-the most common amongst 337 
these being radiography, ultrasound and MRI. This section will predominantly focus on plain 338 
radiography and MRI, as ultrasound has a number of limitations that have constrained its development 339 
and validity in this area including observer dependency its’ inability to assess bone marrow lesions and 340 
to adequately image deep articular joint structures including meniscus and cartilage148. 341 
MRI plays a major role in the OA research setting, with compositional MRI techniques becoming 342 
increasingly more important due to their capacity to assess ‘premorphologic’ biochemical compositional 343 
changes of articular and periarticular tissues. Although radiography remains the primary imaging modality 344 
in OA clinical trials and in daily medical practice, known limitations for visualisation of OA features 345 
significantly limits the utility of radiography both clinically and in the research arena. Ultrasound can be a 346 
useful adjunct to radiography and MRI particularly for the evaluation of synovitis. Emerging hybrid imaging 347 
techniques including PET/MRI and PET/CT allow evaluation of the joint with simultaneous assessment of 348 
morphological changes and metabolic activities, showing a potential for these hybrid systems to play an 349 
increasing role in OA research and clinical practice149. 350 
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Radiographic features of OA are generally classified by the Kellgren and Lawrence (KL) grading system150 351 
and include joint space narrowing, osteophyte formation, sclerosis, and deformity of bony contours151. 352 
Minimum radiographic joint space width (JSW) is the gold standard recommended by the FDA for detecting 353 
structural changes in patients with knee OA in clinical trials. However, standardized measures of 354 
radiographic positioning and fixed location JSW width failed to reach the same degree of responsiveness 355 
in knee OA as quantitative measures of cartilage thickness on MRI152. Indeed, fixed-location radiographic 356 
measures appear not capable of determining the spatial distribution of femorotibial cartilage loss 152. 357 
Moreover, radiographic features such as loss of joint space, sclerosis, and deformity of bone are associated 358 
with late-stage OA and are preceded and detected with greater sensitivity by MRI153.  359 
Conventional MRI enables the evaluation of morphological changes related to early OA, including but not 360 
limited to cartilage damage, meniscal damage, synovitis, presence of BMLs, and ligamentous damage. In 361 
one study of patients with knee pain (n=255, age 40-79 years), BMLs were present in 11% of individuals 362 
without radiographic OA (KL = 0), 38% of individuals with pre-radiographic OA (KL = 1) and 71% of 363 
individuals with radiographic OA (KL >2)153, 154. Similarly, 42% of patients with a diagnosis of symptomatic 364 
OA without radiographic features (KL < 2) had BMLs and 57% had cartilage loss155. Although a paucity of 365 
data exists regarding the timeline of structural changes in the period between a joint injury sustained in 366 
youth and the onset of clinical post-traumatic OA, advanced MRI techniques have been used to detect 367 
subtle cartilage damage at the time of ACL injury156. Furthermore, macroscopic cartilaginous changes, the 368 
presence of BMLs, and bone morpholology changes might be detectable by conventional MRI techniques 369 
as early as two years post ACL reconstruction or other intra-articular knee injury (and potentially before 370 
the development of radiographic OA6, 157-160.  371 
In 2011, a definition of MRI-defined OA was proposed to facilitate earlier detection of OA (Box 2)161, 162. In 372 
one study of patients who had undergone anterior cruciate ligament (ACL) reconstruction, 19% and 17% 373 
of the participants met the MRI criteria for tibiofemoral and patellofemoral OA, respectively, at 1 year163. 374 
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Using the same criteria for MRI-defined OA in patients who participated in a clinical trial of ACL 375 
reconstruction, 31% had tibiofemoral OA and 9% patellofemoral OA, respectively, at 5 years164. 376 
Importantly, some of the changes included in this criteria are undetectable by radiography (i.e. cartilage 377 
thickness, bone marrow lesions). Different methodologies can be used to measure structural changes in 378 
the knee by MRI including the use of semi-quantitative measures (such as the MRI Osteoarthritis Knee 379 
Score (MOAKS)), quantitative measures (including cartilage thickness, bone marrow lesion volume, 380 
effusion-synovitis volume and meniscal extrusion) and measures obtained using compositional imaging 381 
modalities of cartilage (including T2 mapping, T1ρ mapping, delayed gadolinium-enhanced MRI of cartilage 382 
(dGEMRIC), sodium MRI and glycosaminoglycan chemical exchange saturation transfer (gagCEST)) which 383 
measure cartilage composition and quality165. Semiquantitative MRI evaluation can be performed using 384 
several available scoring systems such as the MRI Osteoarthritis Knee Score (MOAKS) and the Anterior 385 
Cruciate Ligament Osteoarthritis Score (ACLOAS)154, 166. For synovitis assessment, contrast-enhanced MRI 386 
should be used and semi-quantitative scoring systems based on contrast-enhanced MRI are available to 387 
enable clear delineation of the synovium from effusion167. In population-based studies, a high proportion 388 
of radiographically normal knees have osteophytes and cartilage damage detectable by MRI illustrating 389 
the greater sensitivity of MRI as compared to radiography153. However, it also highlights the challenge of 390 
what is to be regarded as OA and what is part of a normally ageing joint168. The link between anatomical 391 
evidence of OA and patients’ symptoms and function is still rather weak169, 170. Ultimately, the presence of 392 
these findings on MRI require validation by longitudinal follow-up studies to identify their association with 393 
subsequent illness related to OA (alteration of patient function and symptoms)171 to avoid over-diagnosis 394 
because of incidental MRI findings153, 154, 172-174. Notably, the distinction between pathology and normal 395 
features of the ageing joint is unclear and further research to elucidate the clinical relevance of MRI 396 
findings in early knee OA is warranted. 397 
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Hence, the utility of plain radiography in early OA is limited as only relatively late OA changes are 398 
detectable. As technology improves, assessing changes in bone shape or trabecular bone texture of sub-399 
chondral bone might be of use. MRI has superior sensitivity to change and validity in the context of early 400 
OA153. Although not appropriate for all primary care settings because of the high cost and risk of over-401 
diagnosis, MRI is a critical component of ongoing outcome validation research in early knee OA. 402 
 403 
[H1] Biochemical marker outcomes 404 
Biochemical markers of joint tissue turnover can reflect disease-relevant biological activity that might 405 
precede structural changes detectable on plain radiographs or even by MRI. Markers detected in blood, 406 
urine or synovial fluid may be associated with or predictive of incident radiographic OA. Some biochemical 407 
markers detectable in blood, urine or synovial fluid are associated with or predictive of incident 408 
radiographic OA.  Ideally, biochemical markers of early OA must clearly differentiate between normal 409 
(physiological) and pathological tissue turnover as well as between the early stages of the disease and 410 
more advanced joint destruction. Biochemical markers must also be unaffected by other disorders and be 411 
easily and consistently measurable in a clinical setting175. Biochemical markers of early OA might therefore 412 
be used to identify pre-radiographic changes at the molecular level, facilitate OA drug discovery, and 413 
potentially enable a more rational and personalized approach to healthcare related OA management by 414 
prompting earlier and more targeted treatments and interventions 176.  415 
Studies of incident OA have identified some of the earliest molecular abnormalities associated with OA 416 
and therefore provide biochemical marker candidates for early OA identification. Serum protein 417 
signatures using antibody-based protein microarrays have been shown to detect early radiographic hand 418 
or knee OA. Four serum proteins (matrix metalloproteinase-7, IL-15, plasminogen activator inhibitor-1 419 
and soluble vascular adhesion protein-1) were found to be altered in a cohort of patients with OA 420 
compared to healthy individuals177. Similarly, serum COMP (sCOMP) and hyaluronan concentrations 421 
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could predict178 incident knee joint space narrowing and osteophyte (sCOMP) formation 7 years later in 422 
another patient cohort. In another study, incident radiographic knee OA (based on KL scores) over ten 423 
years was predicted by high serum COMP concentration (based on KL scores) but low serum aggrecan 424 
concentration at the beginning of the study179. Notably, though, molecular and structural biomarkers of 425 
inflammation at two years after an acute ACL injury did not predict structural knee osteoarthritis at five 426 
years164. Mean baseline serum osteocalcin concentrations are associated with 3-year incident 427 
radiographic hand OA (KL >2) but not knee OA in pre-menopausal and peri-menopausal women180. 428 
Bioactive lipids are also potential biochemical markers of pain and inflammation181 and metabolomics 429 
has been used to identify metabolic profiles that can differentiate between synovium samples from 430 
patients with OA and healthy individuals182.  431 
In 2006, the NIH-funded OA Biomarkers Network and the OARSI Clinical Trials Biomarkers Working group 432 
proposed a new classification system for OA biochemical markers termed BIPEDS183, 184. The purpose of 433 
this classification was to clarify the intended primary use of the biochemical marker to reflect Burden of 434 
OA disease, Investigative, Prognostic for OA development, Efficacy of OA intervention, Diagnostic for OA 435 
and Safety of intervention biochemical markers classification system for OA biochemical markers183, 184. 436 
However, a systematic review performed in 2010 concluded that individual biochemical markers and 437 
categories of biochemical markers, including their nature, origin and metabolism, need further 438 
investigation and validation185. In 2016, the FDA-NIH Biomarker Working Group published the BEST 439 
(Biomarkers, EndpointS, and other Tools) glossary186. The BEST resource aims to distinguish between 440 
biochemical markers and clinical assessments and to describe the distinct functions of biochemical 441 
markers in biomedical research, clinical practice, and medical product development. Harmonization of key 442 
terms by BEST avoids inconsistent use of key terms that can hinder the evaluation and interpretation of 443 
scientific evidence. BEST can thereby be expected to facilitate all aspects of biochemical marker work 444 
including testing, validation, commercialization, and perhaps even development for early OA.  445 
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Biochemical and molecular profiling of biological fluids (for example, serum, plasma and synovial fluid) and 446 
joint tissues can provide a global view of the physiologic state of an OA joint. Refinements in omics 447 
approaches and advances in analytical platforms and technologies will enable improved profiling of 448 
different stages of disease. To be clinically useful these biochemical markers need to be properly qualified 449 
(qualification is a regulatory process that links a biochemical marker with biomechanical and/or clinical 450 
outcomes) for early OA and they must adhere to the BEST guidelines to be effectively used in a clinical 451 
setting, rather than in an exploratory and hypothesis testing research setting. 452 
Soluble biochemical markers require further study, validation, and qualification as susceptibility or risk 453 
outcomes for the development of early OA before being adopted for widespread use in the clinical care 454 
setting. 455 
 456 
[H1] Conclusions   457 
 Various outcome domains exist that could be assessed for patients with early knee OA in research and/or 458 
clinical settings, including patient-reported outcomes, clinical features, measures of physical function, 459 
adiposity, physical activity or nutrition and biomechanical, imaging, or biochemical markers. Promising 460 
patient reported outcomes for this purpose include the KOOS and the ICOAP. Measures of physical 461 
outcomes (for example, single leg hop, quadriceps strength) and fat mass index (DXA) are also valid and 462 
reliable. With increasing popularity worldwide, a validated wearable physical activity monitor for 463 
quantifying levels of physical activity and a 3-day weighed food record for nutritional intake (for example, 464 
calories) has potential. MRI-defined OA and biochemical markers, although promising, require specific 465 
healthcare and research facilities where the assessment of these outcomes is possible and body fluids can 466 
be collected, stored and measured according to standard operating procedures. Additional considerations 467 
of patient-preferences and psychosocial outcomes are also important in future research examining early 468 
knee OA outcome measures187. In this regard, further patient-engaged research is recommended. 469 
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Importantly, multiple factors must be considered to facilitate risk assessment and the development of 470 
predictive models for early knee OA. Furthermore, definitions are needed for the potential outcomes, 471 
exposures, confounding and effect-modifying variables, duration of the clinically relevant prediction 472 
period and the setting in which the risk prediction tool will be used. As such, further research validating 473 
outcomes in individuals ‘at risk’ of early OA progression (for example, individuals with an intra-articular 474 
knee injury and/or who are obese) and ‘early-OA’ populations is required. 475 
  476 
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Box 1. Proposed outcomes for the assessment of early pre-radiographic OA 
  
Below we provide suggestions for outcomes measures that could be used to assess individuals with early pre-
radiographic OA in clinical practice and in research settings. Further research is needed, including evaluation 
of validity of early-OA specific outcomes and change in outcomes with progression of OA as many of these 
measures have been evaluated primarily in established OA43, 44, 47-50, 57-59, 66, 153.  
In clinical practice and research settings: 
Patient-reported outcomes 
The Knee Injury and Osteoarthritis Outcome Score (KOOS) can be used to measure pain during activity, other 
symptoms (e.g., stiffness, grinding, catching, swelling, knee flexion and extension, function in daily life and 
during sport and recreational activities, and quality of life across different age and treatment groups. The 
intermittent and constant assessment of pain score (ICOAP) can evaluate constant and intermittent pain  
Clinical examination 
A clinical assessment including joint line tenderness should be performed on individuals with newly-onset 
symptoms of knee pain, stiffness, crepitus, or a feeling of ‘giving way’. 
Functional outcomes 
Three measures seem promising for use in clinical settings on the basis of their reproducibility, patient 
acceptability and the equipment153 and expertise required: Single leg hop test43, 44, 47-50, 30 second chair sit-
to-stand57-59, Star Excursion Balance Test44, 51-56 and quadriceps strength measure44, 47, 48, 52, 66. Multiple 
additional functional measures have been validated for use in research settings. 
Lifestyle-related outcomes 
Adiposity can be assessed by body fat percentage or fat mass index (fat mass/height2) using dual-energy x-
ray absorptiometry or bioelectrical impedance analysis if available. BMI is more feasible in clinical settings, 
although has limitations for use in athletes. Levels of physical activity can be assessed using a validated 
physical activity monitor or a validated questionnaire if objective methods are not available. Nutrition 
outcomes are not currently suggested for use in routine clinical care, however the 3-day dietary record 
provides reliable estimates of nutrient intake. 
In research settings only: 
Biomechanical outcomes 
Measures of biomechanical outcomes require further research and are not currently suggested for use in 
routine clinical care. However, such outcomes are ideal for informing the underlying mechanisms of OA 
progression and informing treatment interventions in research setting. 
Imaging outcomes 
The utility of plain radiography in early OA is limited. Although MRI has superior sensitivity to change and 
validity in the context of early OA 153, and is hence ideal in research settings, MRI is not thought appropriate 
for the routine clinical care setting because of the high cost and potential risk of over-diagnosis. 
Biomarkers 
No biomarkers are currently of use in routine clinical care; however, further validation of proteomic, 
lipidomic and metabolomic tools in research settings could lead to informative cartilage and synovial fluid 
profiles and provide important insights into OA progression. 
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Table 1. Important physical function outcomes    1003 
 1004 
 1005 
 1006 
 1007 
 1008 
 1009 
+ = 1010 
supporting evidence, - = no supporting evidence, +/- = conflicting evidence1011 
Outcome measure Test 
measure 
Equipment 
Required 
Reliability Error Validity Responsive
/Interpreta
bility 
Appropriate 
risk group (age) 
References 
Intra Inter Re- 
test 
Struct
ural 
Ho  
testing 
Single leg hop for 
distance  
Length (cm) Measuring tape + - - - - +/- - Post-trauma 
(≤45 years)  
43, 44, 47-50 
Cross hop for 
distance 
Length (cm) Measuring tape  + - - - - +/- - Post-trauma 
(≤45 years) 
43, 47-50 
6 meter timed hop 
test 
Time (sec) Measuring tape + - - - - + - Post-trauma 
(≤45 years) 
43, 47-50 
Star excursion 
balance test 
Length (% 
leg length) 
Measuring mat, 
tape and skilled 
rater (leg length) 
+ + + + - + - Post-trauma or 
obese (all ages) 
44, 51-56 
30-second chair sit-
to-stand test 
Count  (# 
repetitions)  
Chair and timer + + - - - - - Post-trauma or 
obese (all ages) 
57-59 
6 minute walk test Length (m) Flat 20m walking 
area, timer and 
chair 
- - - - - - - Obese (all ages) 41, 42 
Vertical drop jump Risk rating 31cm high box +   +  - -  -  +/- - Post-trauma 
(≤45 years) 
44, 60 
Single leg squat Risk rating None + + - - +/- +/- - Post-trauma or 
obese (all ages) 
44, 61-63 
Unipedal dynamic 
balance 
Time (sec) Balance pad and 
timer 
- + + - + + - Post-trauma or 
obese (all ages) 
44, 64 
20 meter shuttle run Stage Coloured tape and 
instructions.  
- - + + -/+ + - Post-trauma 
(≤45 years)  
44, 65 
Quadriceps strength Force 
(Nm/Kg) 
Hand-held or 
isokinetic 
dynamometer and 
skilled rater 
+  + +  +  + + + Post-trauma or 
obese (all ages) 
44, 47, 48, 52, 
66 
Hamstring strength Force 
(Nm/Kg) 
Hand-held or 
isokinetic 
dynamometer  
+ + + + +/- +/- +/- Post-trauma or 
obese (all ages) 
41, 43, 67 
Hip adductor or hip 
abductor strength 
Force 
(Nm/Kg) 
Hand-held or 
isokinetic 
dynamometer  
+ + + + - +/- - Post-trauma or 
obese (all ages) 
41, 43, 67 
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Box 2. MRI Defined Osteoarthritis (Hunter et al 2011)161  
 
A definition of tibiofemoral osteoarthritis on MRI would be the presence of both group [A] features or 
one group [A] feature and two or more group [B] features 
 
Group [A] after exclusion of joint trauma within the last 6 months (by history) and exclusion of 
inflammatory arthritis (by radiographs, history and laboratory parameters): 
i) Definite osteophyte formation* 
ii) Full thickness cartilage loss 
 
Group [B]: 
i) Subchondral bone marrow lesion or cyst not associated with meniscal or 
ligamentous attachments 
ii) Meniscal subluxation, maceration or degenerative (horizontal) tear 
iii) Partial thickness cartilage loss (where full thickness loss is not present) 
iv) Bone attrition 
 
A definition of patellofemoral OA requires all of the following involving the patella and/or 
anterior femur: 
i) A definite osteophyte* 
ii) Partial or full thickness cartilage loss 
 1014 
* The definition of a ‘definite osteophyte’ was not delineated in the Delphi process and requires further 1015 
validation. 1016 
